Ampel Biosolutions announced the launch of LuGENE®, a blood test that uses artificial intelligence (AI) to look at a patient’s gene activity and predict when lupus flares are likely to happen and which medications could be most effective to keep symptoms in check.
Lupus Flare Ups Strongly Linked to Specific Bacterial Growth in Gut
Lupus Worsened by Autoantibodies
In an effort to understand the origin of systemic lupus erythematosus and why some patients present with more severe disease than others, Johns Hopkins Medicine researchers say they have identified a type of autoantibody that may worsen the condition and have also found how these autoantibodies originate (Anti-DNA antibodies are a hallmark of patients with SLE.).
Study finds people with lupus have a unique mix of oral bacteria
Study identifies potential new approach for treating lupus
Sleep deprivation tied to lupus risk in women
New molecule shows promise for prevention and treatment of lupus
A new study has found promise in a compound which blocks signals from special receptors in the body thought to be involved in the autoimmune response. More specifically, these receptors are proteins which are designed to detect viral RNA, but mount an autoimmune response when they mistake the body’s own RNA as a threat.
Vitamin D and fish oil supplements may help prevent autoimmune disease
HCQ associated with lower platelet activity and improved vascular health
smoking exposure predicts cutaneous manifestations and damage in SLE
Higher risk of hearing loss with SLE
For lupus mental Health physical activity matters
Studies Show Similar COVID-19 Risk Factors for Patients with Lupus as General Population
Later age menstruation and length of breastfeeding linked to lupus risk in black women
A study indicates that beginning menstruation at age 15 or older and breastfeeding infants for six months or longer may be associated with increased risk for developing lupus in Black women.
Immune cell activation in severe COVID-19 resembles lupus
In severe cases of COVID-19, an exuberant activation of immune cells resembles that seen in acute flares of SLE..
New research from Emory University School of Medicine points towards tests that could separate some COVID-19 patients who need immune-calming therapies from others who may not. It also may begin to explain why some people infected with SARS-CoV-2 produce abundant antibodies against the virus, yet experience poor outcomes.
Drug May Reverse Kidney Damage Caused By Lupus
6 Questions About the Medical and Support Needs of Men With SLE
SLE mostly affects women; however, males represent 4-22% of patients. Research shows men tend to seek medical attention & supportive care < women & are underrepresented at self-management/support services for coping with SLE, despite having higher disease severity. Limited research exists regarding the specific medical, psychosocial, & support needs of men with SLE. Our hospital conducted a national survey to identify self-reported needs & concerns for men with SLE, as well as their interest in male specific support forums.
Can Lupus Be Prevented? Research Reveals Clues to Who’s Most Likely to Transition to Classified Disease
Half of Lupus Rashes Harbor High Levels of Bacteria Responsible for Infections
A new study finds that one side effect of lupus could also make patients with the autoimmune condition more vulnerable to a skin infection, or spreading the infection to others.
In the paper, published in the Journal of Investigative Dermatology, researchers found that 50% of skin rashes in patients with lupus contained an abnormally high presence of a common bacteria responsible for skin infections: staphylococcus aureus, or more commonly known as staph.
9/11 first responders at increased risk for systemic autoimmune disease
Intense dust cloud inhalation, as well as PTSD, experienced by first responders and community members present at the Sept. 11 terrorist attack in New York are associated with a significant increased risk for systemic autoimmune disease, including rheumatoid arthritis and lupus, according to findings published in Arthritis & Rheumatology.